Ciocca, G
Limoncin, E
Di Tommaso, S
Mollaioli, D
Gravina, G L
Marcozzi, A
Tullii, A
Carosa, E
Di Sante, S
Gianfrilli, D
Lenzi, A
Jannini, E A
Article History
Received: 28 October 2013
Revised: 7 July 2014
Accepted: 12 July 2014
First Online: 14 August 2014
Competing interests
: Professor Jannini is a speaker for and consultant to Janssen, Bayer, Lilly, Pfizer and Menarini. All the other authors declare no conflict of interest.